Home / Azithromycin / Japan
JP ATC S01AA26 · updated 2 Nov 2026
Azithromycin shortage in Japan
Is there an Azithromycin shortage in Japan?
Yes. As of 2 Nov 2026, 4 Azithromycin products are reported short in Japan, the first since 15 Jul 2025. No return date has been given. Main reason: increased demand.
Not reported short in any other country we track. All countries.
Affected products in Japan
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| JP | アジスロマイシン錠250mg「DSEP」 limited | 全星薬品工業 | 15 Jul 2025 | not given | Increased demand |
| JP | アジスロマイシン小児用細粒10%「タカタ」 limited | Takata Pharmaceutical | 2 Feb 2026 | not given | Active ingredient shortage Raw material (active ingredient) supply problem |
| JP | アジスロマイシン錠250mg「タカタ」 limited | Takata Pharmaceutical | 19 Oct 2026 | not given | Other |
| JP | アジスロマイシン錠250mg「トーワ」 limited | Towa (Pensa) | 22 Oct 2026 | not given | Increased demand |
Source
MHLW (Ministry of Health, Labour and Welfare), supply status of prescription medicines. Official list. Prescription products under limited shipment or supply suspension (delistings excluded); one row per product.